<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02523872</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00064591</org_study_id>
    <nct_id>NCT02523872</nct_id>
  </id_info>
  <brief_title>Description of Fluid Balance in Patients With Acute Respiratory Failure</brief_title>
  <official_title>Description of Fluid Balance in Patients With Acute Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smiths Medical, ASD, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smiths Medical, ASD, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The specific aim of this study is to gather data on fluid balance, intravenous medication
      administration, electrolyte balance, and diuretic and dialysis use in patients with acute
      respiratory failure who might benefit from a strategy designed to limit fluid administration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Disruption of fluid balance is common in critical illness. Many critical illnesses are
      inflammatory in nature and associated with capillary leak and swelling of tissues. While
      fluid administration may be necessary for the immediate resuscitation of a patient in shock,
      in the long term it may worsen survival and lead to complications. This is especially true in
      acute respiratory failure, where excess fluid can lead to a longer duration of mechanical
      ventilation, longer time in the ICU, and a greater need for dialysis. There is also evidence
      that conservative fluid administration can prevent complications. Fluid overload is
      associated with increased healthcare resource utilization and cost.

      Much of the fluid administered to patients while in the adult ICU in the United States is
      administered as medications via large volume infusion pumps. This is a descriptive study to
      gather data on fluid balance, intravenous medication administration, electrolyte balance, and
      diuretic and dialysis use in patients with acute respiratory failure who might benefit from a
      strategy designed to limit fluid administration. The information will be used to design an
      interventional trial of small volume medication infusion.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 Days</time_frame>
    <description>Discharged from hospital alive or expired</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventilator-free days</measure>
    <time_frame>28 Days</time_frame>
    <description>Number of days of being alive and unassisted breathing by 28 days after time=0</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ICU-free days</measure>
    <time_frame>28 Days</time_frame>
    <description>Number of days alive and out of ICU-level care by 28 days after time=0</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dialysis use</measure>
    <time_frame>28 Days</time_frame>
    <description>Use of intermittent hemodialysis, continuous renal replacement therapy (CvvH, CvvHD), ultrafiltration (intermittent or SCUF), or aquapheresis (Aquadex™)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sequential Organ Failure Assessment (SOFA)</measure>
    <time_frame>28 Days</time_frame>
    <description>Mean and highest scores after T=0</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>Acute respiratory failure</arm_group_label>
    <description>Patients with acute respiratory failure who might benefit from a strategy designed to limit fluid administration</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute respiratory failure who might benefit from a strategy designed to limit
        fluid administration
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intubation and mechanical ventilation for ≤ 7 days

          -  An underlying condition associated with acute respiratory failure (e.g. pneumonia,
             ARDS, sepsis, asthma, COPD exacerbation)

          -  If in shock (MAP &lt; 60, fluid bolus ≥30 ml/Kg or 4 L crystalloid or equivalent,
             vasopressors except for dopamine ≤ 5 mcg/kg/min or low-dose (≤ 0.04 IU/min)
             vasopressin) there should be no fluid bolus (1000 mL crystalloid or equivalent) for at
             least 12 hours

        Exclusion Criteria:

          -  Intubation or mechanical ventilation for &gt; 7 days

          -  Respiratory failure (requirement for positive pressure ventilation) in past 30 days

          -  Shock (MAP &lt; 60, fluid bolus ≥30 ml/Kg or 4 L crystalloid or equivalent, vasopressors
             except for dopamine ≤ 5 mcg/kg/min or low-dose vasopressin) requiring fluid bolus
             (1000 mL crystalloid or equivalent) within past 12 hours

          -  Presence of a condition making it unlikely that the patient will be liberated from
             mechanical ventilation within the next 28 days (e.g. quadriplegia, end-stage lung
             disease, massive stroke, etc.)

          -  Prognosis from underlying condition ≤ 28 days (estimated 28 day mortality from
             underlying condition &gt;50%)

          -  Likely intention (&gt;50% probability) to withhold or withdraw life-supportive care
             within next 28 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl Shanholtz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov 8;345(19):1368-77.</citation>
    <PMID>11794169</PMID>
  </reference>
  <reference>
    <citation>Alsous F, Khamiees M, DeGirolamo A, Amoateng-Adjepong Y, Manthous CA. Negative fluid balance predicts survival in patients with septic shock: a retrospective pilot study. Chest. 2000 Jun;117(6):1749-54.</citation>
    <PMID>10858412</PMID>
  </reference>
  <reference>
    <citation>Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011 Jun 30;364(26):2483-95. doi: 10.1056/NEJMoa1101549. Epub 2011 May 26.</citation>
    <PMID>21615299</PMID>
  </reference>
  <reference>
    <citation>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006 Jun 15;354(24):2564-75. Epub 2006 May 21.</citation>
    <PMID>16714767</PMID>
  </reference>
  <reference>
    <citation>Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ørding H, Lindorff-Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, Gramkow CS, Okholm M, Blemmer T, Svendsen PE, Rottensten HH, Thage B, Riis J, Jeppesen IS, Teilum D, Christensen AM, Graungaard B, Pott F; Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg. 2003 Nov;238(5):641-8.</citation>
    <PMID>14578723</PMID>
  </reference>
  <reference>
    <citation>Li G, Malinchoc M, Cartin-Ceba R, Venkata CV, Kor DJ, Peters SG, Hubmayr RD, Gajic O. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med. 2011 Jan 1;183(1):59-66. doi: 10.1164/rccm.201003-0436OC. Epub 2010 Aug 6.</citation>
    <PMID>20693377</PMID>
  </reference>
  <reference>
    <citation>Child DL, Cao Z, Seiberlich LE, Brown H, Greenberg J, Swanson A, Sewall MR, Robinson SB. The costs of fluid overload in the adult intensive care unit: is a small-volume infusion model a proactive solution? Clinicoecon Outcomes Res. 2014 Dec 15;7:1-8. doi: 10.2147/CEOR.S72776. eCollection 2015.</citation>
    <PMID>25548524</PMID>
  </reference>
  <reference>
    <citation>Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001 Oct 10;286(14):1754-8.</citation>
    <PMID>11594901</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2015</study_first_submitted>
  <study_first_submitted_qc>August 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2015</study_first_posted>
  <last_update_submitted>August 13, 2015</last_update_submitted>
  <last_update_submitted_qc>August 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fluid overload</keyword>
  <keyword>Acute respiratory failure</keyword>
  <keyword>Acute respiratory distress syndrome</keyword>
  <keyword>Medication administration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

